Abbas N,Irfan M,Hussain A,Arshad MS,Hussain SZ,Latif S,Bukhari NI .2018 .Development and evaluation of scaffold-based nanosponge formulation for controlled drug delivery of naproxen and ibuprofen. Trop. J. Pharm. Res., 17(8) : 1465-1474.
Ansari K A,Vavia P R F,Cavalli R F .2011 .Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study. AAPS Pharm. Sci. Tech, 12(1) : 279-286.
Ashraf S,Saeed G,Muhammad S,Saify ZS,Haider S,Sayed SA,Ali R,Siddiqui F,Simji S F .2019 .Potential nutraceutical benefits of basmati rice bran oil as analgesic, anti-inflammatory and anti-arthritis. Pak. J. Pharm. Sci., 32(6) : 2545-2551.
Jung S Cho E .2015 .Supramolecular complexation of carbohydrates for the bioavailability enhancement of poorly soluble drugs. Molecules, 20(10) : 19620-19646.
Cirri M,Maestrelli F,Corti G,Furlanetto S,Mura P .2006 .Simultaneous effect of cyclodextrin complexation, pH, and hydrophilic polymers on naproxen solubilization. J. Pharm. Biomed. Anal., 42(1) : 126-131.
Dugar RP,Gajera BY,Dave RH BY .2016 .Fusion method for solubility and dissolution rate enhancement of ibuprofen using block copolymer poloxamer 407. AAPS Pharm. Sci. Tech, 17(6) : 1428-1440.
Felton LA,Popescu C,Wiley C,Esposito EX,Lefevre P,Hopfinger AJ .2014 .Experimental and computational studies of physicochemical properties influence NSAID-cyclodextrin complexation. AAPS Pharm. Sci. Tech, 15(4) : 872-881.
Ghorab MK,Adeyeye MC .2001 .Elucidation of solution state complexation in wet-granulated ovendried ibuprofen and β-cyclodextrin: FT-IR and 1HNMR studies. Pharm, 6(3) : 315-324.
Hasnain MS,Nayak AK .2012 .Solubility and dissolution enhancement of ibuprofen by solid dispersion technique using PEG 6000-PVP K 30 combination carrier. Chemistry, 21(1) : 118-132.
Hussain A,Smith G,Khan KA,Bukhari NI,Pedge NI,Ermolina I .2018 .Solubility and dissolution rate enhancement of ibuprofen by co-milling with polymeric excipients. Eur. J. Pharm. Sci., 123(1) : 395-403.
Irvine J,Afrose A,Islam N A .2018 .Formulation and delivery strategies of ibuprofen: Challenges and opportunities. Drug Dev, 44(2) : 173-183.
Javadzadeh Y,Ahadi F,Davaran S,Mohammadi G,Sabzevari A,Adibkia K A .2010 .Preparation and physicochemical characterization of naproxen-PLGA nanoparticles. Colloids Surf B Biointerfaces, 81(2) : 498-502.
Khalid Q,Ahmad M,Minhas MU,Batool F,Malik NS,Rehman M .2021 .Novel β-cyclodextrin nanosponges by chain growth condensation for solubility enhancement of dexibuprofen: Characterization and acute oral toxicity studies. J. Drug Deliv. Sci. Technol, 61(1) : 102089.
Martin R,Sánchez I,Cao R,Rieumont J .2006 .Solubility and kinetic release studies of naproxen and ibuprofen in soluble epichlorohydrin-β-cyclodextrin polymer. Supramol. Chem, 18(8) : 627-631.
Mello VA,Ricci-Junior E .2011 .Encapsulation of naproxen in nanostructured system: structural characterization and in vitro release studies. Quim Nova, 34(6) : 933-939.
Milhem O,Myles C,McKeown N,Attwood D,D'Emanuele A .2000 .Polyamidoamine Starburst® dendrimers as solubility enhancers. Int. J. pharm., 197(1-2) : 239-241.
Mumuni A M F C,Chime S A,Ogbonna J D and Mora A .2014 .Anti-inflammatory and pharmacokinetics evaluation of PEGylated ibuprofen tablet formulation. Drug Deliv, 21(4) : 315-319.
Nokhodchi A,Amire O,Jelvehgari M .2010 .Physico-mechanical and dissolution behaviours of ibuprofen crystals crystallized in the presence of various additives. Daru, 18(2) : 74.
Olteanu AA,Arama CC,Bleotu C,Lupuleasa D,Monciu CM .2015 .Investigation of cyclodextrin based nanosponges complexes with angiotensin I converting enzyme inhibitors (Enalapril, captopril. Farmacia, 63(4) : 492-503.
Omar S M F,Ismail A .2020 .Formulation and evaluation of cyclodextrin-based nanosponges of griseofulvin as pediatric oral liquid dosage form for enhancing bioavailability and masking bitter taste. Saudi Pharm. J., 28(3) : 349-361.
Paul S,Akhter S,Hasan I,Haider SS,Reza MS .2013 .Encapsulation of Naproxen in Eudragit RSPO Microsphere system: In vitro characterization and compatibility studies. Dhaka Univ. J. Pharm. Sci., 11(2) : 147-155.
Pushpalatha R,Selvamuthukumar S,Kilimozhi D S .2018 .Cross-linked, cyclodextrin-based nanosponges for curcumin delivery-Physicochemical characterization, drug release, stability and cytotoxicity. J. Drug Deliv. Sci. Technol, 45(1) : 45-53.
Ragab D M and Rohani S .2009 .Particle engineering strategies via crystallization for pulmonary drug delivery. Org. Process Res. Dev., 13(6) : 1215-1223.
Rao M,Bajaj A,Khole I,Munjapara G,Trotta F G .2013 .In vitro and in vivo evaluation of β- cyclodextrin-based nanosponges of telmisartan. J. Incl. Phenom. Macrocycl. Chem, 77(1-4) : 135-145.
Rao MR,Bhingole RC .2015 .Nanosponge-based pediatric-controlled release dry suspension of Gabapentin for reconstitution. Drug Dev, 41(12) : 2029-2036.
Rao MR,Chaudhari J,Trotta F,Caldera F F .2018 .Investigation of cyclodextrin-based nanosponges for solubility and bioavailability enhancement of rilpivirine. AAPS Pharm. Sci. Tech, 19(5) : 2358-2369.
Rao M R and Shirsath C .2017 .Enhancement of bioavailability of non-nucleoside reverse transciptase inhibitor using nanosponges. AAPS Pharm. Sci. Tech, 18(5) : 1728-1738.
Reis CP,Ferreira JP,Candeias S,Fernandes C,Martinho N,Aniceto N,Cabrita AS,Figueiredo IV .2014 .Ibuprofen nanoparticles for oral delivery: proof of concept. J. Nanomedicine Biotherapeutic Discov., 4(1) : 1.
Rojas-Mena A R,López-Gonzalez H and RojasHernández A A R .2015 .Preparation and characterization of holmium-beta-cyclodextrin complex. AMPC, 5(03) : 87.
Salústio P,Feio G,Figueirinhas J,Pinto J,Marques H C .2009 .The influence of the preparation methods on the inclusion of model drugs in a β-cyclodextrin cavity. Eur. J. Pharm. Biopharm., 71(2) : 377-386.
Sbora R,Budura E A,Nitulescu G M T,Lupuleasa D .2015 .-cyclodextrin and hydroxypropyl-α-cyclodextrin. Farmacia, 63(4) : 548-555.
Dravyakar Sherje A P,Kadam B R,Jadhav D,M D .2017 .Cyclodextrin-based nanosponges: A critical review. Carbohydr, 173(1) : 37-49.
Shringirishi M,Prajapati SK,Mahor A,Alok S,Yadav P,Verma A .2014 .Nanosponges: A potential nanocarrier for novel drug delivery-a review. Asian Pac. J. Trop. Dis., 4(1) : 519-526.
Su J,Chen J,Li L,Li B,Shi L,Zhang H,Ding X H .2012 .Preparation of natural borneol/2- hydroxypropyl-β-cyclodextrin inclusion complex and its effect on the absorption of tetramethylpyrazine phosphate in mouse. Chem. Pharm. Bull., 60(6) : 736-742.
Suthakaran C and Senthil G .2018 .Evaluation of analgesic and anti-inflammatory activity of ibuprofenpregabalin in animal models. J. Clin. Diagn. Res., 12(9) : 5-8.
Swaminathan S,Pastero L,Serpe L,Trotta F,Vavia P,Aquilano D,Trotta M,Zara G,Cavalli R G .2010 .Cyclodextrin-based nanosponges encapsulating camptothecin: physicochemical characterization, stability and cytotoxicity. Eur. J. Pharm. Biopharm., 74(2) : 193-201.
Tejashri G,Amrita B,Darshana J .2013 .Cyclodextrin based nanosponges for pharmaceutical use: A review. Acta Pharmaceutica, 63(3) : 335-358.
Torne S,Darandale S,Vavia P,Trotta F,Cavalli R F .2013 .Cyclodextrin-based nanosponges: Effective nanocarrier for tamoxifen delivery. Pharm. Dev, 18(3) : 619-625.
Trotta F,Cavalli R,Tumiatti W,Zerbinati O,Roggero C,Vallero R C .2008 .Ultrasound-assisted synthesis of cyclodextrin-based nanosponges. WO2006002814A1., : .
Trotta F,Zanetti M,Cavalli R M .2012 .Cyclodextrinbased nanosponges as drug carriers. Beilstein J. Org. Chem, 8(1) : 2091-2099.
Woldum H S Larsen K L and Madsen F .2008 .Cyclodextrin controlled release of poorly water-soluble drugs from hydrogels. Drug Delivery, 15(1) : 69-80.
Yaşayan G,Şatıroğlu Sert B,Tatar E,Kucukgüzel İ .2020 .Fabrication and characterisation studies of cyclodextrin-based nanosponges for sulfamethoxazole delivery. J. Incl. Phenom. Macrocycl. Chem, 97(1) : 175-186.
Zainuddin R,Zaheer Z,Sangshetti J N and Momin M .2017 .Enhancement of oral bioavailability of antiHIV drug rilpivirine HCl through nanosponge formulation. Drug Dev, 43(12) : 2076-2084.
Zaman H .2016 .Addressing solubility through nano based drug delivery systems. J. Nanomed Nanotechnol, 7(3) : 1-7.
Zidan M F E A .2018 .In vitro and in vivo evaluation of cyclodextrinbased nanosponges for enhancing oral bioavailability of atorvastatin calcium. Drug Dev, 44(8) : 1243-1253.